SEC filings by ACUTUS MED INC (ownership)| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|
| SC 13D/A | 2023-11-13 | Flynn James E | Acutus Medical, Inc. | 5,731,096 | 5.5% | EDGAR |
| SC 13G/A | 2023-02-13 | Capital World Investors | Acutus Medical, Inc. | 797,523 | 2.8% | EDGAR |
| SC 13D/A | 2022-07-05 | Flynn James E | Acutus Medical, Inc. | 5,731,096 | 5.7% | EDGAR |
| SC 13D/A | 2022-04-27 | Flynn James E | Acutus Medical, Inc. | 3,841,587 | 5.7% | EDGAR |
| SC 13G/A | 2022-02-14 | Advent Life Sciences LLP | Acutus Medical, Inc. | 1,617,149 | 5.8% | EDGAR |
| SC 13G/A | 2022-02-11 | Kerrisdale Advisers, LLC | Acutus Medical, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2022-02-11 | Capital World Investors | Acutus Medical, Inc. | 1,600,000 | 5.7% | EDGAR |
| SC 13D/A | 2021-11-18 | ORBIMED ADVISORS LLC | Acutus Medical, Inc. | 2,648,386 | 9.5% | EDGAR |
| SC 13D/A | 2021-08-31 | ORBIMED ADVISORS LLC | Acutus Medical, Inc. | 6,881,953 | 7.7% | EDGAR |
| SC 13D/A | 2021-08-26 | Flynn James E | Acutus Medical, Inc. | 3,841,587 | 5.8% | EDGAR |
| SC 13D/A | 2021-07-21 | Flynn James E | Acutus Medical, Inc. | 3,841,587 | 11.3% | EDGAR |
| SC 13G | 2021-07-21 | Kerrisdale Advisers, LLC | Acutus Medical, Inc. | 1,750,920 | 5.2% | EDGAR |
| SC 13D/A | 2021-07-14 | ORBIMED ADVISORS LLC | Acutus Medical, Inc. | 5,810,525 | 20.4% | EDGAR |
| SC 13D/A | 2021-07-13 | Flynn James E | Acutus Medical, Inc. | 3,160,995 | 11.1% | EDGAR |
| SC 13G | 2021-02-11 | Zahir Fares | Acutus Medical, Inc. | 1,166,690 | 4.2% | EDGAR |
| SC 13G | 2021-02-10 | Advent Life Sciences LLP | Acutus Medical, Inc. | 1,617,149 | 5.8% | EDGAR |
| SC 13D | 2020-08-20 | Flynn James E | Acutus Medical, Inc. | 3,160,998 | 11.4% | EDGAR |
| SC 13D | 2020-08-18 | ORBIMED ADVISORS LLC | Acutus Medical, Inc. | 5,810,525 | 20.9% | EDGAR |